Quantcast

Global Pharmas Choose Thought Leader Select as Vendor of Choice for KOL Initiatives

June 25, 2013

Canadian subsidiaries of global biopharmaceutical firms retain Thought Leader Select for key opinion leader and centers of excellence medical outreach to Canadian leaders in cardiology, gastroenterology, and genetics.

Chapel Hill, North Carolina (PRWEB) June 25, 2013

Canadian subsidiaries of a pair of top-15 global biopharmaceutical companies have appointed Thought Leader Select as their preferred research and engagement advisor for key opinion leader initiatives in multiple therapeutic areas.

Thought Leader Select, headquartered in Chapel Hill, North Carolina, provides research and advisory services to companies in the life sciences industry, including pharmaceutical, biotechnology, medical device, and diagnostics companies, as they reach out to and collaborate with leading medical experts to advance treatment options and promote better health worldwide.

Each company has approved Thought Leader Select as its preferred vendor for a variety of projects and retained advisory services centering on the work of key opinion leaders and centers of excellence in medicine. Key opinion leaders, also known as thought leaders and key external experts, lead the medical field with their research, clinical practice, publishing in scientific journals, patient advocacy, treatment guidelines, and more. Centers of excellence include the high-impact teaching hospitals, medical schools, specialty clinics, and research foundations known for breakthrough research and cutting-edge clinical practice.

For the coming set of engagements, Thought Leader Select will profile the skills and experience of key opinion leaders in cardiology, gastroenterology, and genetics, as the projects center around treatments for heart failure, opioid-induced constipation, and a collection of rare and orphan diseases.

Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of these leading experts in multiple areas where they collaborate to advance the science of medicine and patient care. The company will deliver multiple tools for client decision support, including comprehensive profiles highlighting relevant skills and experience of the medical experts, impact maps that showcase clusters of key opinion leaders who routinely collaborate in their work, and customized engagement plans that provide a foundation for utilizing the right key opinion leaders for the right activities.

The engagements will also feature geographic impact analysis, since the client companies will be working with leaders at local, regional, national, and global levels.

The research group will also study centers of excellence in these therapeutic areas, assessing the leaders in research, publishing, and clinical practice, as well as noting institutional programs and initiatives for residency, fellowships, and patient advocacy. At the conclusion of the research assessments of the key opinion leaders and centers of excellence in cardiology, gastroenterology, and genetics, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening relationships with key opinion leaders and centers of excellence in support of medical affairs and marketing plans.

“We’re honored to have earned the trust of these two companies, both leaders in delivering new treatments across multiple therapeutic areas,” stated Neil Mellor, Thought Leader Select’s global business development consultant based in Toronto. “Thought Leader Select has earned preferred vendor status through the integrity of our work—it’s comprehensive and actionable, and we’ve given these two companies the data and advice they need to make critical decisions for working with the medical community.”

About Thought Leader Select

Thought Leader Select is a Chapel Hill, NC-based private consulting firm serving the biopharmaceutical, medical device, and diagnostics industries with strategies, in-house research, and a suite of engagement tools and support for collaborating with and reaching out to key opinion leaders and centers of excellence in medicine.

Thought Leader Select has supported companies as they develop effective treatments to promote better patient and public health across more than 18 therapeutic areas and 50 diseases and conditions. Thought Leader Select’s customized work strengthens medical marketing initiatives, medical affairs outreach, and payer marketing strategies to support market access, pricing, and reimbursement issues.

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/6/prweb10854146.htm


Source: prweb



comments powered by Disqus